Licensing deals are crucial for accelerating the development of innovative cancer treatments. They enable the sharing of intellectual property (IP) and resources, which can lead to faster and more cost-effective development processes. Additionally, licensing deals can help smaller biotech firms gain access to the larger infrastructure and capabilities of big pharmaceutical companies.
